3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
4
Lymphoma, Mantle-Cell
4
Colorectal Neoplasms
4
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Glioblastoma
3
Waldenstrom Macroglobulinemia
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Gliosarcoma
2
Glioma
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Interventions
Pharmacogenomic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adult Patients Who Are Receiving Oncologic Care
×
Pharmacogenomic Testing
×
Clear all
NCT06511401
2026-05-04
C-PAIN
University of Chicago
Phase NA
Recruiting
800 enrolled